Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2025-12-24 @ 11:40 PM
NCT ID:
NCT06492551
Eligibility Criteria:
Inclusion Criteria:
* Patients that have suffered COVID-19 \[COVID-19-moderate: clinical signs of pneumonia (fever, cough, dyspnea, tachypnea), but without signs of severe pneumonia, particularly oxygen saturation greater than or equal to 90% with air atmosphere; COVID-19-severe: clinical signs of pneumonia (fever, cough, dyspnea, tachypnea) plus one of the following: frequency respiratory \> 30 inspirations/min; severe dyspnea; treatment oral medication.\]
* Patients with COVID-19-related muscle pain.
* Patients with a personal device such as a tablet, smartphone, or laptop operate agilely with these devices.
* Patients with email.
* Signing of the informed consent.
Exclusion Criteria:
* Patients with a resting heart rate higher than 110 beats per minute.
* Patients with blood pressure less than 90/60 or over 160/95.
* Patients with lower blood oxygen saturation of 90%.
* Patients with advanced cognitive impairment.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06492551
Study Brief:
Protocol Section:
NCT06492551